Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market
完整報告名稱與涵蓋範圍
Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market Size, Share & Trends Analysis Distribution by Product Type (Combined Nutritional Supplements, Single Nutritional Supplements), Type Indication (Perimenopause, PMS), Formulation (Capsules/Tablets, Powder, Softgels), Sales Channel (Pharmacies/Drug Stores, Online Sales Channel, Direct Sales Channel) and Segment Forecasts, 2024-2031
報告摘要
The Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market is positioned for steady expansion, with a projected CAGR of 5.3% from 2024 to 2031.
The Premenstrual Syndrome (PMS) and Menstrual Health Supplements sector involves a widespread condition impacting millions of women globally. This domain has witnessed marked transformation owing to technological breakthroughs and shifting healthcare dynamics.
Growth is fueled by a convergence of factors: rising awareness among end users, continuous product innovation, and the expanding emphasis on efficiency and sustainability within the healthcare sector.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, fueled by rapid industrialization and expanding end-user bases.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market Snapshot
Chapter 4. Global Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Product Type Estimates & Trend Analysis
5.1. by Product Type & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Product Type:
5.2.1. Combined Nutritional Supplements
5.2.2. Single Nutritional Supplements
5.2.2.1. Vitamins
5.2.2.2. Minerals
5.2.2.3. Herbal Supplements
5.2.2.4. Others
Chapter 6. Market Segmentation 2: by Indication Estimates & Trend Analysis
6.1. by Indication & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Indication:
6.2.1. Perimenopause
6.2.2. PMS
Chapter 7. Market Segmentation 3: by Formulation Estimates & Trend Analysis
7.1. by Formulation & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Formulation:
7.2.1. Capsules/Tablets
7.2.2. Powder
7.2.3. Softgels
7.2.4. Others
Chapter 8. Market Segmentation 4: by Sales Channel Estimates & Trend Analysis
8.1. by Sales Channel & Market Share, 2019 & 2031
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Sales Channel:
8.2.1. Pharmacies/Drug Store
8.2.2. Online Sales Channel
8.2.3. Direct Sales Channel
8.2.4. Others
Chapter 9. Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2023-2031
9.1.2. North America Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2023-2031
9.1.3. North America Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market Revenue (US$ Million) Estimates and Forecasts by Formulation, 2023-2031
9.1.4. North America Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market Revenue (US$ Million) Estimates and Forecasts by Sales Channel, 2023-2031
9.1.5. North America Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
9.2. Europe
9.2.1. Europe Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2023-2031
9.2.2. Europe Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2023-2031
9.2.3. Europe Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market Revenue (US$ Million) Estimates and Forecasts by Formulation, 2023-2031
9.2.4. Europe Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market Revenue (US$ Million) Estimates and Forecasts by Sales Channel, 2023-2031
9.2.5. Europe Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
9.3. Asia Pacific
9.3.1. Asia Pacific Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2023-2031
9.3.2. Asia Pacific Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2023-2031
9.3.3. Asia-Pacific Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market Revenue (US$ Million) Estimates and Forecasts by Formulation, 2023-2031
9.3.4. Asia-Pacific Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market Revenue (US$ Million) Estimates and Forecasts by Sales Channel, 2023-2031
9.3.5. Asia Pacific Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
9.4. Latin America
9.4.1. Latin America Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2023-2031
9.4.2. Latin America Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2023-2031
9.4.3. Latin America Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market Revenue (US$ Million) Estimates and Forecasts by Formulation, 2023-2031
9.4.4. Latin America Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market Revenue (US$ Million) Estimates and Forecasts by Sales Channel, 2023-2031
9.4.5. Latin America Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
9.5. Middle East & Africa
9.5.1. Middle East & Africa Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2023-2031
9.5.2. Middle East & Africa Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2023-2031
9.5.3. Middle East & Africa Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market Revenue (US$ Million) Estimates and Forecasts by Formulation, 2023-2031
9.5.4. Middle East & Africa Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market Revenue (US$ Million) Estimates and Forecasts by Sales Channel, 2023-2031
9.5.5. Middle East & Africa Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Maxar Space Systems
10.2.2. Herbalife International of America, Inc.
10.2.3. Nature's Bounty Co.
10.2.4. Amway Corporation
10.2.5. Pharmavite LLC
10.2.6. GNC Holdings, Inc.
10.2.7. USANA Health Sciences, Inc.
10.2.8. Power Gummies
10.2.9. Health and Her Ltd.
10.2.10. RBK Nutraceuticals Pty Ltd.
10.2.11. Looni
10.2.12. Ora Organic
10.2.13. SMP Nutra
10.2.14. Nature's Way
10.2.15. Pure Encapsulations, LLC.
10.2.16. Keffy
10.2.17. Other Prominent Players
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們